GABRA1
Reaktivität: Ratte
WB, IHC, ICC, IF
Wirt: Maus
Monoclonal
S399-19
PE
Applikationshinweise
The antibody has been directly tested for reactivity in Western blots with rat and mouse tissue.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
100 μLin 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per mL BSA and 50 % glycerol.
Lagerung
-20 °C
Informationen zur Lagerung
GABAA Receptor antibody can be stored at -20°C and is stable at -20°C for at least 1 year.
Target
GABRA1
(gamma-aminobutyric Acid (GABA) A Receptor, alpha 1 (GABRA1))
Andere Bezeichnung
GABAA Receptor
Hintergrund
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system, causing a hyperpolarization of the membrane through the opening of a Cl- channel associated with the GABAA receptor (GABAA-R) subtype. GABAA-Rs are important therapeutic targets for a range of sedative, anxiolytic, and hypnotic agents and are implicated in several diseases including epilepsy, anxiety, depression, and sub-stance abuse. The GABAA-R is a multimeric subunit complex. To date six alphas, four betas and four gammas, plus alternative splicing variants of some of these subunits, have been identified (Olsen and Tobin, 1990, Whiting et al., 1999, Ogris et al., 2004). Injection in oocytes or mammalian cell lines of cRNA coding for alpha- and beta-subunits results in the expression of functional GABAA-Rs sensitive to GABA. However, coexpression of a gamma-subunit is required for benzodiazepine modulation. The various effects of the benzodiazepines in brain may also be mediated via different alpha-subunits of the receptor (McKernan et al., 2000, Mehta and Ticku, 1998, Ogris et al., 2004, Pöltl et al., 2003).